|

Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes

RECRUITINGN/ASponsored by Ramsay Générale de Santé
Actively Recruiting
PhaseN/A
SponsorRamsay Générale de Santé
Started2022-03-20
Est. completion2028-04-01
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted

Summary

In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros. This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patient, male or female, over the age of 18
* Patient with a FINDRISC score ≥10 points
* Beneficiary of a French health insurance system
* Patient having been informed and having given their consent free, enlightened and written

Exclusion Criteria:

* Patient over 75 years old
* Patient already diagnosed with type 2 diabetes
* Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
* Patient participating in another research
* Patient in period of exclusion from another research always in progress at the time of inclusion.
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.
* Pregnant, breastfeeding or parturient women.
* Patient hospitalized without consent

Conditions2

Diabete Type 2Diabetes

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.